Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar

P. M. Fracasso, K. A. Blum, M. K. Ma, B. R. Tan, L. P. Wright, S. A. Goodner, C. L. Fears, W. Hou, M. A. Arquette, J. Picus, A. Denes, J. E. Mortimer, L. Ratner, S. P. Ivy, H. L. McLeod

Research output: Contribution to journalArticlepeer-review

28 Scopus citations

Fingerprint

Dive into the research topics of 'Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodar'. Together they form a unique fingerprint.

Medicine & Life Sciences